Vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and cardiovascular dysfunction
Open Access
- 11 June 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 12 (7), 841-845
- https://doi.org/10.1038/nm1426
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Impact of Increased Heart Rate on Clinical Outcomes in HypertensionDrugs, 2006
- Amyand’s hernia: a case report of prospective ct diagnosis in the emergency departmentEmergency Radiology, 2005
- The Sympathetic Nervous System and HypertensionHypertension, 2004
- Endoglin regulates nitric oxide‐dependent vasodilatationThe FASEB Journal, 2004
- Vav1/2/3-null Mice Define an Essential Role for Vav Family Proteins in Lymphocyte Development and Activation but a Differential Requirement in MAPK Signaling in T and B CellsThe Journal of Experimental Medicine, 2003
- VAV proteins as signal integrators for multi-subunit immune-recognition receptorsNature Reviews Immunology, 2002
- Vascular Remodeling in HypertensionHypertension, 2001
- ABC of hypertension: The pathophysiology of hypertensionBMJ, 2001
- Hypertension and the heartJournal of Human Hypertension, 2000
- Ruptured Appendicitis in Femoral HerniasAnnals of Surgery, 1974